Martha E Shenton is an expert in Psychiatry at Brigham and Women's Hospital (United States). As of October 2026, ScienceLeadR ranks Martha E Shenton in the top 1% of experts worldwide for Schizotypal Personality Disorder, Schizophrenia and Schizophrenia Spectrum and Other Psychotic Disorders. Martha E Shenton has authored 738 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 2 of them ongoing. SLR score: 3,416 (community average: 125). How the SLR is computed.

LeadR Profile

Martha E Shenton Brigham and Women's Hospital United States
3 416 ScienceLeadR Reputation 3416
Network Map

Psychiatry

Subspecialties: Neurology - Psychology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

Martha E. Shenton is a leading neuroscientist and professor of psychiatry and radiology at Harvard Medical School. She is also the Director of the Psychiatry Neuroimaging Laboratory at Brigham and Women’s Hospital. Her research has significantly advanced the understanding of brain abnormalities in psychiatric and neurological disorders, particularly schizophrenia and traumatic brain injury (TBI).


Dr. Shenton is best known for her pioneering work using structural magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) to investigate abnormalities in brain structure and connectivity. In schizophrenia research, her studies have revealed consistent findings of structural disruptions in regions such as the hippocampus, amygdala, and white matter tracts, contributing to the biological understanding of the disorder.


She has also been instrumental in applying advanced neuroimaging techniques to study mild traumatic brain injury (mTBI), including sports- and blast-related concussions. Her work has helped identify subtle changes in brain tissue that are not detectable with conventional imaging methods, offering new pathways for diagnosis and monitoring of recovery. She has also published findings in high-impact journals with her collaborators on neuroimaging findings in post-traumatic stress disorders.


Throughout her career, Dr. Shenton has published extensively in high-impact journals and has collaborated across disciplines to integrate neuroimaging, neuropsychology, and symptomatology in those suffering from schizophrenia and schizophrenia related disorders. She serves, and has served, on numerous editorial boards, NIMH study sections, and has received several awards recognizing her contributions to neuroscience and mental health research. She has also received the William Silen Lifetime Achievement Award in Mentoring from Harvard Medical School. She has trained many clinical researchers in the field, who are now running successful research laboratories and serving as professors, department chairs, and deans at several medical schools worldwide.


(AI ChatGPT was used as a starting point for writing this short biography)

Organizations

Career arc: 1984 - 2026

Source: PubMed

Mass General Brigham (MGB)

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 738

Citations

Citations: 49 359 1st author: 23 Last author: 138 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The role of white matter microstructure in the association between childhood maltreatment and adult post-traumatic symptoms.
PMID 42859210 — white matter, stress disorders, post-traumatic, mental disorders, signs and symptoms, neurosciences, stress disorders, traumatic, wounds and injuries, post-concussion syndrome
Mol Psychiatry20260
Regional ventricular enlargement as an in vivo biomarker of cumulative biomechanical neurodegeneration in former American football players.
PMID 42675309 — dementia, neuroimaging, alzheimer disease, lateral ventricles, biomarkers, chronic traumatic encephalopathy, football
Alzheimers Dement20260
Centrally Acting Medications, Chronic Pain, and Orthopedic Surgical History Among Former American Football Players.
PMID 42664488 — chronic pain, pain, cognitive dysfunction, orthopedics, signs and symptoms, brain diseases, cognition disorders, brain injuries, traumatic, diagnosis, behavioral symptoms, history, neurology, football
Neurology20260
Disentangling white matter correlates of symptom severity and general impairment in early psychosis.
PMID 42618605 — depression, white matter, molecular biology, mental disorders, neurosciences, psychotic disorders
Mol Psychiatry20260
Adolescent trajectories of psychotic-like experiences and autistic traits and their association with cognition, environmental adversity, and white matter microstructure in the ABCD Study.
PMID 42567269 — white matter, psychopathology, mental disorders, signs and symptoms, adolescent, cognition
Biol Psychiatry Cogn Neurosci Neuroimaging20260

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

N/A 3
Phase 1/Phase 2 1
Phase 2 1

By status:

Completed 3
Active not recruiting 1
Recruiting 1

By type:

Observational 3
Interventional 2

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 1
multicentric5to9 0
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis
NCT07226895 — safety, biomarkers, therapeutics, psychotic disorders
Phase 1/Phase 2Recruiting2026
AMP SCZ Observational Study PREDICT DPACC
NCT05905003 — biomedical research, phenotype, algorithms, biomarkers, schizophrenia, research, psychotic disorders
N/AActive not recruiting2022

LeadR Networks

Main global connection map